Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

NCT00417144 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome
Ovarian Hyperstimulation Syndrome

Interventions

DRUG: Arvekap 0.1mg (Triptorelin, Ipsen, France)
DRUG: Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands)

Sponsor

Eugonia